INSIGHTS ON ENTERPRISE SOLUTIONS
-
Top 5 Cell Line Development Challenges (And How To Avoid Them)
Five key cell line development pitfalls—scalability, stability, complexity, analytics, and tech transfer—can derail biologics programs without experienced partners and integrated, predictive development strategies.
-
Optimize Your CLD With Innovative And Flexible Transposase Technology
To ensure speed and stability in the manufacture of your complex biologic — mAbs, antibodies, fusion proteins, and/or antibody drug conjugates — prioritize a high-performance CLD workflow.
-
Achieve Speed, Stability, And Compliance In Cell Line Development
Partnering with a CDMO that demonstrates innovative and commercially validated cell line development capabilities is essential to protecting your market position and securing investor support.
-
Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.
In this episode of "Better Biopharma," host Tyler Menichiello is joined by Bonum Therapeutics' chief scientific officer, Diane Hollenbaugh, Ph.D., and chief business officer, Neela Patel, Ph.D.
-
Single-Use Assembly Configurator Tutorial10/31/2025
Master the essentials of single-use assembly design. Learn how a step-by-step configurator with 3D renderings simplifies complex fluid management challenges and accelerates your process.
-
Navigating Digital Transformation For Pharmaceutical CDMOs10/31/2025
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Non-Viral And Large-Scale Delivery Of Gene Editing Tools10/29/2025
Explore an advanced electroporation platform that enables reliable, large-scale, non-viral delivery of complex gene editing tools like CRISPR/Cas9 for T-cell manufacturing.
-
Enhancing CRISPR Knock-In And Knock-Out10/29/2025
Achieve scalable, non-viral CRISPR delivery for T cells. The next-generation electroporation platform provides robust, efficient gene editing from small to large-scale volumes.
ENTERPRISE SOLUTIONS
-
Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.
-
With a foundation built on operational excellence, cutting-edge technology, and strategic capacity expansion, we’re equipped to overcome the most demanding manufacturing challenges.
-
Explore flexible single-use bioprocessing systems, from standard to fully customized, covering mixing, filtration, buffer prep, and storage, designed to boost production and ensure contamination control.
-
Achieve superior AAV production yields in suspension HEK293 cells. This chemically-defined media system offers flexibility, robust growth, and can boost viral titers up to 4x.
-
Engineered recombinant cytokines ensure consistent, high-quality cell signaling across research and clinical applications. They closely mimic native human form, supporting robust, scalable protocols.